A Bill of "Rights" for patients with COPD: the "right" therapy for the "right" patient at the "right" time.

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000;160:1683–9. 11. Shahab L, Jarvis MJ, Britton J, et al. Chronic obstructive pulmonary disease prevalence, diagnosis and relation to tobacco dependence in a nationally representative population sample. Thorax 2006;61:1043–7. 12. Kim SJ, Suk MH, Choi HM, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis 2006;10:1393–8. 13. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368: 804–13. 14. Friedlander AL, Lynch D, Dyar LA, et al. Phenotypes of chronic obstructive pulmonary disease. COPD 2007;4:355–84. 15. Kelley CF, Mannino DM, Homa DM, et al. Asthma phenotypes, risk factors, and measures of severity in a national sample of US children. Pediatrics 2005;115:726–31. 16. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007;357:1946–55. 17. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007;370:758–64.